Please turn JavaScript on
Psychedelics Today icon

Psychedelics Today

Receive updates from Psychedelics Today for free, starting right now.

We can deliver them by email, via your phone or you can read them from a personalised news page on follow.it.

This way you won't miss any new article from Psychedelics Today. Unsubscribe at any time.

Site title: Expert-informed media and education | Psychedelics Today

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.29 / day

Message History

Three people with lasting symptoms after a brain injury went through a six-week iboga microdosing protocol paired with therapy. Two improved and held those gains. One relapsed. A new case series in Frontiers in Pharmacology is going to circulate widely—here's what it can and can't tell us, why the dose question matters, and where the sourcing gets uncomfortable.

The po...


Read full story

MAPS policy lead Sia Henry argues that psychedelic healing can't stop at veterans and the clinic door. It has to reach the communities the War on Drugs was built to target, starting before incarceration, not after.

The post The War on Drugs W...


Read full story

At the Federal Summit on Psychedelic Medicine, policymakers, researchers, clinicians, and veterans advocates spent a day working through the real implementation challenges facing the field from REMS and rescheduling to ARPA-H's $139 million EVIDENT initiative and the ethics of informed consent.

The post


Read full story

If you’ve ever sat with a client in a ketamine or psilocybin session and quietly wondered whether you chose the right songs for your playlist, you’re not alone, and you’re already asking the right question. Music is not just for creating a nice atmosphere in psychedelic-assisted therapy. It is, as researcher Mendel Kaelen put it […]

The post


Read full story

Travis Tyler Fluck joins Joe Moore to discuss Denver mushroom decriminalization, the legacy of Initiative 301, Microdose Mondays, mutual aid, personal use, psychedelic community ethics, and the tension between regulated access and grassroots medicine.

The post


Read full story